# Progress Note 05 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ernest Hemingway (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET003-SYN
- Date: 2026-06-08
- Fictional facility: St. Posthumous Health Center
- Fictional author: Walter Brandt-Ochoa, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Fourteen-week review: phlebotomy, stopping alcohol, mood and blood pressure. **S**

## History of present illness

Mr. Hemingway returns fourteen weeks after intake and four weeks after the sick visit; the hand healed completely after the antibiotics. He came down by one drink a week as planned and has had no alcohol for three weeks. He had two nights of poor sleep after the last drink and no tremor, sweating or confusion. He keeps taking naltrexone and says the evening craving is weaker. He has had ten phlebotomies, with one skipped in the week of the hand infection, and the eleventh is planned after today's blood tests. Sertraline 100 mg causes no side effects; his mood is better and his PHQ-9 is 8, but no PHQ-9 had been done since the six-week visit. Home blood pressure averages 134/84. Headaches are down to one or two a week. His guns remain at the club. The echocardiogram has still not been done: the order went to an imaging center that never contacted him. **S**

| Element | Detail |
|---|---|
| Alcohol | None for three weeks after a gradual reduction; AUDIT-C 3 for the past month |
| Withdrawal | Two nights of poor sleep; no tremor or confusion |
| Phlebotomy | Ten sessions (one skipped); the eleventh today |
| Mood | PHQ-9 8; item 9 scored 0 |
| Home blood pressure | Average 134/84 |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | More energy; weight down 3 kg since intake |
| Integumentary | Negative | Hand healed |
| Neurological | Positive | Headaches once or twice a week; no tremor |
| Psychiatric | Positive | Mood better; sleeping six hours; no thoughts of suicide or wishes to be dead since the last visit |

4 systems reviewed. **S**

## Current medications

- Naltrexone 50 mg oral tablet, one tablet daily, to reduce heavy drinking **S**
- Thiamine 100 mg oral tablet, one tablet daily **S**
- Sertraline 100 mg oral tablet, one tablet daily **S**
- Amlodipine 10 mg oral tablet, one tablet daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 134/84 mmHg; pulse 76 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 94.6 kg; BMI 28.2 kg/m². All vital signs are synthetic.

Hemoglobin: 13.6 g/dL; MCV: 96 fL; AST: 32 U/L; ALT: 36 U/L; GGT: 58 U/L; Ferritin: 620 ng/mL (high); PHQ-9: 8; AUDIT-C: 3. All results are synthetic.

## Change since baseline

- Hemoglobin: 15.6 g/dL at baseline, 13.6 g/dL at this visit **S**
- MCV: 102 fL (high) at baseline, 96 fL at this visit **S**
- AST: 70 U/L (high) at baseline, 32 U/L at this visit **S**
- ALT: 78 U/L (high) at baseline, 36 U/L at this visit **S**
- GGT: 196 U/L (high) at baseline, 58 U/L at this visit **S**
- Ferritin: 1460 ng/mL (high) at baseline, 620 ng/mL (high) at this visit **S**
- PHQ-9: 16 at baseline, 8 at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 134/84, pulse 76; weight 94.6 kg |
| Skin | Right hand healed without redness |
| Abdomen | Liver edge not palpable; no spleen felt |
| Neurological | No tremor |
| Psychiatric | Brighter and more talkative |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Hereditary hemochromatosis on weekly phlebotomy** (E83.110). Ferritin 620 ng/mL after ten sessions; hemoglobin 13.6 g/dL. On track for the target in about three to four months. **S**
   - Continue weekly phlebotomy.
2. **Alcohol use disorder, severe, in early remission** (F10.20). No alcohol for three weeks after a gradual reduction, with no significant withdrawal. Liver tests are now normal. **S**
   - Continue naltrexone for at least six to twelve months.
   - Stop thiamine at the six-month visit if he remains abstinent and eats well.
   - Plan for social occasions and travel made in therapy.
3. **Depression on sertraline** (F32.1). PHQ-9 8 from 16. Safety reviewed: no thoughts of suicide or wishes to be dead; he has chosen to keep the guns at the club for now; the 988 Suicide & Crisis Lifeline in his phone. **S**
   - Continue sertraline 100 mg daily.
   - PHQ-9 monthly by the behavioral health clinician, recorded in the chart.
4. **Hypertension** (I10). Home average 134/84, still above target despite less alcohol and weight loss. **S**
   - Increase amlodipine to 10 mg daily; check for ankle swelling.
   - Echocardiogram rebooked through the clinic's own scheduler.
5. **Post-concussion symptoms** (F07.81). Headaches fewer and thinking clearer since he stopped drinking. **S**
   - Repeat MoCA at the six-month visit.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Laboratory | Hemoglobin before each phlebotomy (hold if under 12.0 g/dL) | Before every session; full blood count at visits | Completed today | Hemoglobin 13.6 g/dL, MCV 96 fL; no session held for anemia |
| Laboratory | Serum ferritin during induction phlebotomy | At diagnosis, then about every 10 to 12 phlebotomies; target 50 to 100 ng/mL | Completed today | Ferritin 620 ng/mL after ten sessions |
| Medication safety | Weekly phlebotomy of 500 mL | Weekly during induction | Completed today | Ten sessions; one held in the week of the hand infection; the eleventh today |
| Imaging | Liver cancer surveillance | Every six months only with cirrhosis or advanced fibrosis | Not indicated | No advanced fibrosis on MRI |
| Self-management | Diet: no iron or vitamin C supplements, no raw shellfish | Every visit | Completed today | No supplements; no raw shellfish |
| Laboratory | Liver tests on naltrexone | Baseline, about one month, then every three to six months | Completed today | AST 32, ALT 36 and GGT 58 U/L; normal |
| Survey | Drinking quantity and goal (AUDIT-C, drinking diary) | Every visit | Completed today | AUDIT-C 3 for the past month; none for three weeks |
| Medication safety | Opioid use and pain plan on naltrexone | Every visit | Completed today | No opioids; none needed for the hand |
| Examination | Alcohol withdrawal risk and symptoms when cutting down or stopping | When stopping | Completed today | Gradual reduction; two nights of poor sleep only |
| Medication safety | Thiamine | Daily while drinking heavily | Completed today | Taking thiamine; review at six months |
| Survey | Depression (PHQ-9) | At least monthly during acute treatment | Deferred | PHQ-9 8 today, eight weeks after the last score, longer than the monthly check advised; the sick visit did not repeat it. No harm resulted: his weekly therapist saw steady improvement and today's score is lower. Corrective action: PHQ-9 monthly by the behavioral health clinician, recorded in the chart |
| Medication safety | Sertraline adherence and side effects | Two weeks after starting or changing the dose, then each visit | Completed today | 100 mg; reviewed by the behavioral health clinician two weeks after the increase; no side effects |
| Survey | Suicide-risk review (C-SSRS screen since the last visit), safety plan, firearm storage and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | C-SSRS screen negative since the last visit; firearms remain off-site by his choice |
| Self-management | Psychotherapy (CBT) | Weekly | Completed today | Attending weekly |
| Examination | Blood pressure, home readings, weight and cardiac auscultation | Every visit | Completed today | 134/84 in clinic; home average 134/84; weight 94.6 kg; amlodipine increased |
| Imaging | Echocardiogram | At diagnosis of stage 2 hypertension | Deferred | Not done fourteen weeks after it was ordered: the order went to an outside imaging center that never contacted him. No harm so far: no symptoms, no murmur, and the ECG showed only borderline voltage. Corrective action: rebooked through the clinic's scheduler, with the result checked at the six-month visit |
| Examination | Post-concussion symptoms (headache frequency, sleep, concentration) | Every visit | Completed today | Headaches once or twice a week |

## Goal progress

- Drinking goal chosen by him: no more than two drinks a day and none before evening, then reconsidered once the liver results are known. Outcome by 2026-06-08: Reduced to three or four drinks a day by six weeks; he then chose to stop, and has had no alcohol for three weeks. **S**
- Ferritin 50 to 100 ng/mL with weekly phlebotomy, then maintenance. In progress; target 2026-08-31. **S**
- PHQ-9 below 5. In progress; target 2026-08-31. **S**
- Blood pressure below 130/80 mmHg. In progress; target 2026-08-31. **S**
- Fewer headaches and clearer thinking, so that he can write. In progress; target 2026-08-31. **S**

## Medication changes

- Stopped: Amlodipine 5 mg oral tablet, one tablet daily **S**
- Started: Amlodipine 10 mg oral tablet, one tablet daily **S**

## Guideline basis

- Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases (2011), American Association for the Study of Liver Diseases (Hepatology 2011;54(1):328-343)
- ACG Clinical Guideline: Hereditary Hemochromatosis (2019), American College of Gastroenterology (Am J Gastroenterol 2019;114(8):1202-1218)
- The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder (2018), American Psychiatric Association (Am J Psychiatry 2018;175(1):86-90)
- The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management (2020), American Society of Addiction Medicine (Journal of Addiction Medicine)
- VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024), United States Department of Veterans Affairs and Department of Defense
- VA/DoD Clinical Practice Guideline for the Management and Rehabilitation of Post-Acute Mild Traumatic Brain Injury (2021), United States Department of Veterans Affairs and Department of Defense
- CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026), Aether Forge

## Follow-up

- Weekly phlebotomy. Monthly PHQ-9 with the behavioral health clinician. Echocardiogram before the six-month visit. Preventive visit in seven weeks. Six-month review in twelve weeks with blood count, iron studies, liver tests, HbA1c, lipids, PHQ-9, AUDIT-C and MoCA. **S**
- Next scheduled visit 2026-07-27: periodic adult preventive visit. **S**
